Home » Medical Devices » Bioabsorbable Stent/Bioresorbable Scaffold Market Size, Share, Analysis Report
In drugs, tubing is any device that is inserted into a vessel or alternative internal duct so as to expand the vessel to stop or alleviate a blockage. Historically, such devices are unreal from metal mesh and stay within the body for good or till removed through more surgical intervention. A bioresorbable tubing, (also known as perishable, or naturally-dissolving) serves a similar purpose, however is factory-made from a fabric which will dissolve or be absorbed within the body.
How Big is The Global Bioabsorbable Stent/Bioresorbable Scaffold Market?
The Bioabsorbable Stent/Bioresorbable Scaffold Market is expected to be around US$ 685 Million by 2028 at a CAGR of 11% in the given forecast period.
The major driving factors of Bioabsorbable Stent/Bioresorbable Scaffold Market are as follows:
The restraining factors of Bioabsorbable Stent/Bioresorbable Scaffold Market are as follows:
The Bioabsorbable Stent/Bioresorbable Scaffold Market is segmented on the lines of its material, absorption rate, application end-user and regional. Based on material type, the market is segmented bioresorbable polymer-based stents and bioresorbable metallic stents. Based on absorption type it covers slow-absorption stents and fast-absorption stents. Based on application it covers Coronary Artery Diseases and Peripheral Artery Diseases. Based on end-users it covers hospitals and cardiac centers. Allergy Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Bioabsorbable Stent/Bioresorbable Scaffold Market.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Bioabsorbable Stent/Bioresorbable Scaffold Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report scope:
The scope of the report includes a detailed study of Bioabsorbable Stent/Bioresorbable Scaffold Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:
By Application Type:
By Material type:
By Absorption Type:
By End Consumers:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Bioabsorbable Stent/Bioresorbable Scaffold Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Bioabsorbable Stent/Bioresorbable Scaffold Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Hysteroscopy Instruments Market
Intravascular Temperature Management Market
1 Introduction
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Market Research Tactics
2.1 Research Approach
2.2 Primary Research
2.3 Secondary Research
2.4 Vital Industry Insights
2.5 Market Size Evaluation
3 Market Summary
4 Quality Market Insights
4.1 Bioresorbable Stents Market Overview
4.2 By End User
4.3 By Application
4.4 By Material
4.5 Regional Market Snapshot
5 Market Bioresorbable Stents Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapidly Growing Geriatric Population And Increased Risk Of Cad And Pad In The Elderly
5.2.1.2 Strong Product Pipeline
5.2.2 Restraints
5.2.2.1 Presence Of Substitutes
5.2.3 Opportunities
5.2.4 Challenges
6 Regulatory Market Synopsis
6.1 Introduction
6.2 Fda And Ce Approvals
6.3 Pma Approvals And Government Certificates
7 Bioresorbable Stents Market, By Application
7.1 Introduction
7.2 Bioresorbable Metallic Stents
7.3 Bioresorbable Polymer-Based Stents
8 Bioresorbable Stents Market, By Absorption Rate
8.1 Introduction
8.2 Slow-Absorption Stents
8.3 Fast-Absorption Stents
9 Bioresorbable Stents Market, By Material
9.1 Introduction
9.2 Coronary Artery Disease
9.3 Peripheral Artery Disease
10 Bioresorbable Stents Market, By End Consumer
10.1 Introduction
10.2 Hospitals
10.3 Cardiac Centers
11 Bioresorbable Stents Market, By Geographic Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia Pacific
11.5 Rest Of The World
12 Competitive Landscape
12.1 Introduction
12.2 Market Ranking Analysis
12.3 Competitive Leadership Analysis
12.4 Competitive Benchmarking
12.4.1 Strength Of The Product Portfolio
12.4.2 Business Strategy Excellence
13 Company Profiles
(Company Overview, Product Portfolio, Financial Overview, Key Devolopements)*
13.1 Kyoto Medical Planning Co., Ltd.
13.2 Reva Medical, Inc.
13.3 Elixir Medical Corporation
13.4 480 Biomedical
13.5 Biotronik
13.6 Amaranth Medical, Inc.
13.7 Arterial Remodeling Technologies
13.8 Meril Life Sciences Pvt. Ltd.
13.9 Arterius Limited
13.10 Orbusneich
13.11 Boston Scientific Corporation
13.12 Lepu Medical Technology Co., Ltd.
13.13 S3v Vascular Technologies Private Limited
13.14 Qualimed (Part Of Q3 Medical Group)
13.15 Abbott
The Bioabsorbable Stent/Bioresorbable Scaffold Market has been segmented as below:
By Application Type:
By Material type:
By Absorption Type:
By End Consumers:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS